Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 2.49M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -1.74M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -9.00% |
| Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -34.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -72.00% |
| Recommedations | - | Quick Ratio | 0.00 | Shares Outstanding | 61.65M | 52W Low Chg | 93.00% |
| Insider Own | 50.10% | ROA | -915.34% | Shares Float | 22.95M | Beta | 1.75 |
| Inst Own | 3.16% | ROE | - | Shares Shorted/Prior | -/- | Price | 0.12 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 10,155 | Target Price | - |
| Oper. Margin | - | Earnings Date | Oct 2 | Volume | 4,396 | Change | -0.30% |
About NOVACCESS GLOBAL INC
NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.
NOVACCESS GLOBAL INC News
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| LAIRD NEIL J | Chief Financial Offi.. Chief Financial Officer | Jan 20 | Buy | 0.20 | 250,000 | 50,000 | 260,000 | 01/21/22 |